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Abstract 15 
The transition from late pregnancy to early lactation is a critical period in a dairy cow`s life due to 16 
the rapidly increasing drain of nutrients from the maternal organism towards the foetus and into 17 
colostrum and milk. In order to cope with the challenges of parturition and lactation, comprehensive 18 
adaptive reactions comprising the endocrine and the immune system need to be accomplished. 19 
There is high variation in this coping ability and both metabolic and infectious diseases, 20 
summarized as “production diseases”, such as hypocalcaemia (milk fever), fatty liver syndrome, 21 
laminitis and ketosis, may occur and impact welfare, productive lifespan and economic outcomes. 22 
Proteomics and metabolomics have emerged as valuable techniques to characterize proteins and 23 
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metabolite assets from tissue and biological fluids, such as milk, blood and urine. In this review we 24 
provide an overview on metabolic status and physiological changes during the transition period and 25 
the related production diseases in dairy cows, and summarize the state of art on proteomics and 26 
metabolomics of biological fluids and tissues involved in metabolic stress during the peripartum 27 
period. We also provide a current and prospective view of the application of the recent 28 
achievements generated by omics for biomarker discovery and their potential in diagnosis. 29 
 30 
Significance  31 
For high-yielding dairy cows there are several “occupational diseases” that occur mainly during the 32 
metabolic challenges related to the transition from pregnancy to lactation. Such diseases and their 33 
sequelae form a major concern for dairy production, and often lead to early culling of animals. 34 
Beside the economical perspective, metabolic stress may severely influence animal welfare. There 35 
is a multitude of studies about the metabolic backgrounds of such so called production diseases like 36 
ketosis, fatty liver, or hypocalcaemia, although the investigations aiming to assess the complexity of 37 
the pathophysiological reactions are largely focused on gene expression, i.e. transcriptomics. For 38 
extending the knowledge towards the proteome and the metabolome, the respective technologies are 39 
of increasing importance and can provide an overall view of how dairy cows react to metabolic 40 
stress, which is needed for an in-depth understanding of the molecular mechanisms of the related 41 
diseases. We herein review the current findings from studies applying proteomics and 42 
metabolomics to transition-related diseases, including fatty liver, ketosis, endometritis, 43 
hypocalcaemia and laminitis. For each disease, a brief overview of the up to date knowledge about 44 
its pathogenesis is provided, followed by an insight into the most recent achievements on the 45 
proteome and metabolome of tissues and biological fluids, such as blood serum and urine, 46 
highlighting potential biomarkers. We believe that this review would help readers to be become 47 
more familiar with the recent progresses of molecular background of transition-related diseases thus 48 





The transition period from late pregnancy to early lactation is a critical period in a dairy cow`s life 52 
due to the rapidly increasing drain of nutrients from the maternal organism towards the foetus and 53 
into colostrum and milk. During this transition period, fetal growth reaches its exponential course 54 
during the last weeks of pregnancy and concomitantly the mammary gland parenchyma mass 55 
markedly grows [1]. After calving, the output of nutrients with milk exceeds the input by voluntary 56 
feed intake. The negative nutrient balance (NNB) resulting therefrom requires a massive 57 
mobilization of body reserves, mainly body fat but also protein. Albeit NNB is a common 58 
phenomenon in mammals, both the duration and the extent observed in modern high yielding dairy 59 
cows represent a biological extreme. To be able to cope with the challenges of parturition and 60 
lactation, comprehensive adaptive mechanisms comprising the endocrine and the immune system 61 
need to be accomplished. There is high variation in this coping ability and both metabolic and 62 
infectious diseases, summarized as “production diseases”, may occur and have an impact on 63 
welfare, productive lifespan and economic outcomes. The incidence of such diseases is greatest 64 
during early lactation with hypocalcaemia (milk fever), fatty liver syndrome and ketosis (or 65 
acetonaemia) being the most common metabolic diseases. In case of infectious diseases, metritis 66 
and mastitis, attributable to the immune-compromised situation during the metabolic challenge, are 67 
most frequent. Fig.1 presents the relationship between metabolic stress and disease development. 68 
Several studies have attempted to identify the causes and risk factors associated with the high 69 
incidence of health problems observed during the periparturient period [2–5], and systems biology 70 
approaches addressing the issue of the regulatory mechanisms of nutrient metabolism in lactation 71 
are published [6–8] . Beside environmental factors, production diseases also have a genetic 72 
component; e.g. for subclinical macromineral disorders and major clinical diseases the heritability 73 
reported were low to moderate [9].  74 
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To further investigate the complexity of these diseases, omics approaches which include multi-75 
variate, and large-scale analyses, may be applied. Such studies gather information either at the level 76 
of the DNA, RNA, miRNA, protein or the metabolites, and provide a snapshot of the current 77 
condition in cells, tissues or body fluids (Fig 2). However, variation in sampling times between 78 
different studies can yield different results and it is important to take this into account when 79 
interpreting omics results or planning further studies. The multivariate results from omics 80 
approaches require extensive bioinformatics resources that are mostly available online. Both 81 
proteomics and metabolomics have evolved as the functional continuation of transcriptomics in less 82 
than two decades, and have developed rapidly, due to improvements in technology and 83 
bioinformatics tools. General reviews about the application of proteomics and metabolomics to 84 
livestock science were published earlier [10–12]. Both proteomics and metabolomics involve the 85 
resolution of a complex mixture of compounds into components that can then be identified and 86 
characterized. For what concerns proteins, their identification always involves matching each the 87 
amino acid sequence to the respective encoding gene and thus depends of the sequence information 88 
available for the target species, but can also include the description of posttranslational protein 89 
modifications.  90 
Two major mass spectrometry (MS) platforms are available for proteomics, following the 91 
mechanism through which ions are generated: these ion sources are termed matrix-assisted laser 92 
desorption/ionization (MALDI) and electrospray ionization (ESI). Before analysis, proteins are 93 
fractionated either by electrophoretic, for intact proteins, or chromatographic, for peptides generated 94 
after protein cleavage, techniques. Protein fractions are then digested, to generate peptides that can 95 
be further fractionate by chromatographic techniques and then characterized by MS, which can 96 
record the mass of analytes to generate information about their structure. The resulting data are 97 
further analysed with search engines, such as Mascot (Matrix Science Ltd), to generate in silico MS 98 
data for the specified genome sequence database.  99 
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Absolute protein quantification is difficult to achieve with proteomics techniques. On the contrary, 100 
relative quantitation can be achieved by gel-based methods, such as 2DE using semiquantitative 101 
protein stains, or protein labeling strategies, such as difference gel electrophoresis (DIGE) [13]. As 102 
an example, DIGE was applied to blood serum samples to identify potential biomarkers related to 103 
hypocalcaemia [14]. 104 
At the peptide level, relative quantification can be achieved by stable isotope-labeling approaches 105 
(iTRAQ) or by label-free comparison. Isolated proteins or tryptic peptides can be chemically 106 
labeled before separation (iTRAQ) [15]. Quantification of proteins by means of iTRAQ was used, 107 
among the others, to identify liver proteins related to physiological imbalance [16]. 108 
For metabolites, species-specificity is not an issue albeit relative quantities may differ. The major 109 
analytical approaches used in metabolomics rely on two techniques: MS and NMR techniques [17]. 110 
For MS-based techniques, samples are fractionated through chromatographic techniques such as 111 
Gas Chromatography (GC) of High Pressure Liquid Chromatography (HPLC), or capillary 112 
electrophoresis. The GC is used to fractionate volatile metabolites, such as for example BHB of 113 
other organic acids, or fatty acids, whereas HPLC is used for lipophilic metabolites, such as acyl 114 
carnitines for example. Fractionated metabolites are then ionized and identified following mass 115 
spectrometry analysis. NMR techniques can identify simultaneously all the analytes, and do not 116 
require any prefractionation of the sample. Successful identification of individual metabolites 117 
depends of high quality mass spectra, powerful spectral matching algorithms and comprehensive 118 
and reliable spectral libraries [18]. 119 
Metabolomics strategies are commonly divided into targeted and non-targeted metabolomics. 120 
Targeted metabolomics aims to quantify defined groups of metabolites, such as for example, in case 121 
of transition period-related diseases, acylcarnitines, carbohydrates, amino acids or organic acids. 122 
Internal standards, such as stabile isotope (1H and 13C) labelled metabolites are used to measure 123 
analytes in a quantitative or semi-quantitative ways [19]. Non-targeted metabolomics allows for the 124 
detection of all the metabolites in a sample, in theory. Indeed, non-targeted metabolomics is able to 125 
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detect up to 10,000 independent spectral features in biological samples [20], but only a fraction of 126 
them can be actually identified. Targeted metabolomics was already applied in several dairy cow 127 
studies e.g. to characterize the respective changes in blood throughout the transition phase [21–24] 128 
and non-targeted metabolomics for testing a supplement aiming to ameliorate metabolic stress [25], 129 
respectively. The aim of this review is to provide an overview of the state of the art applications of 130 
proteomics and metabolomics to address production diseases of dairy cows, whose prevention 131 
represents a priority for intensive milk production. We reconcile and summarize the information 132 
currently available on metabolic status and physiological changes during the transition period, and 133 
discuss the most recent achievements in proteomics and metabolomics applications for biomarker 134 
discovery, their potential as diagnostic tools, but also for comprehension of complex (patho) 135 
physiological contexts. However, the review will be largely limited to metabolic diseases and to 136 
metritis. For mastitis, the reader is referred to the specific “mastitomics” literature [26–28] and also 137 
to the latest considerations of meta-proteomics and meta-metabolomics which include the milk 138 
microbiome as recently reviewed by Addis and coworkers [29]. 139 
Metabolomics by means of near infrared spectroscopy is used since many years in routine milk 140 
recordings to assess gross milk composition (mainly the content of fat, protein and lactose), but is 141 
also increasingly considered for minor milk constituents to provide information about the 142 
physiological status of the animals [30]. Such information could be used for herd management 143 
decisions and for phenotyping in animal breeding as well. However, to be able to relate the spectra 144 
obtained to certain metabolites and, in consequence, to identify health disturbances, circumspect 145 
validations and algorithms are necessary [31–33]. Those applications are beyond the scope of this 146 
review that will be limited to the identification of metabolites related to production diseases in 147 
tissues, mainly liver and adipose tissue, and biological fluids, such as blood, but also urine and milk 148 
where appropriate. 149 
 150 
Metritis and endometritis  151 
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The uterine mucosal environment is protected, in principle, from invading pathogens by physical 152 
anatomical barriers and molecular mechanisms. However, dairy cows may develop endometritis or 153 
metritis (an inflammation of the inner mucosal layer of the uterus, or of the entire uterine wall, 154 
respectively), when these mechanisms are compromised. The opening of the cervix for giving birth 155 
as well as tissue lesions related to labour and expulsion of the calf and placental membranes violate 156 
the anatomical barriers, concomitantly the innate immune defense is suppressed thus facilitating 157 
bacterial infections that cause metritis and endometritis [34]. These diseases have a high incidence 158 
postpartum [35–37] and often result in decreased fertility as shown by reduced conception rates and 159 
increased calving-to-conception intervals [38].  160 
A pioneering proteomic study provided first clues about the alterations in blood serum in 161 
pathological (endometritis) versus physiological states [39]. Patterns indicative for an inflammatory 162 
reaction were also found in healthy animals around calving as demonstrated by increasing 163 
concentrations of positive acute phase proteins (APP), such as 1-acid glycoprotein (AGP) and 164 
haptoglobin, and a correspondent decrease of negative APP, such as 2HS glycoprotein (fetuin-A) 165 
suggesting that the approaching calving resembles an acute-phase reaction. This is in line with the 166 
common observation of an inflammatory reaction peripartum that is considered as physiological and 167 
even necessary for the successful adaptation to the metabolic challenge as recently reviewed [40]. 168 
In the proteome study [39], the concentrations of AGP two weeks before calving were lower in 169 
animals that developed endometritis postpartum, but were higher two weeks after calving, 170 
suggesting AGP not only as a potential prepartum bioindicator for an early detection of an increased 171 
risk for endometritis but also indicating a complex functional role for AGP in the context of 172 
endometritis.  173 
In a 2-DGE analysis followed by MALDI-TOF, endometritis-associated proteins were identified in 174 
endometrial samples [41]. Several proteins, including desmin, α-actin-2, heat-shock protein (HSP) 175 
27, peroxiredoxin-6, luteinizing hormone receptor isoform 1, collectin-43 precursor, 176 
deoxyribonuclease-I (DNase-I), and MHC class I heavy chain (MHC-Ih) were up-regulated in 177 
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endometritis, whereas, transferrin, interleukin-2 precursor, hemoglobin β subunit, and potassium 178 
channel tetramerisation domain containing 11 (KCTD11) were down-regulated as compared to 179 
normal endometrium. Desmin and α-actin-2 identified in this proteomic study to be related with 180 
endometritis are common in mammalian cells, but being also up-regulated during other diseases, 181 
such as cancer [42], they would not qualify as specific biomarkers for endometritis. However, truly 182 
specific associations between the proteins found to be divergently regulated are unlikely anyway, in 183 
view of the pleiotropic defense reactions. Fig. 3 summarizes the differences in proteomes of blood 184 
and endometrial samples associated with the development of metritis. When comparing the uterine 185 
proteome of cows infected with a specific bacterium (Trueperella pyogenes - formerly 186 
Arcanobacterium), with that of uninfected cows, using 2-DGE , annexins A1 and A2 (ANXA1 and 187 
ANXA2), apolipoprotein A-1, calprotectin (S100A9), cathelicidin, enolase 1 (ENO1), 188 
peptidoglycan recognition protein 1 (PGLYRP1), phosphoglycerate mutase 1 (PGAM1), serine 189 
dehydratase (SDS) and serine protease inhibitors (SERPIN) B1, B3 and B4 proteins were found to 190 
be differentially regulated [43]. In the second part of the study ten of these proteins were monitored 191 
in uterine samples from dairy cows at 15 and 42 days post-partum, and strong positive correlations 192 
between the cytology scores (percentage of polymorphonuclear neutrophils) and cathelicidin, 193 
PGLYRP1, SERPINB1 and S100A9 levels at day 15 were found. 194 
Retention of the placenta e.g. the failure to expel the placenta within 12 - 24 h after calving, is 195 
known as a major predisposing factor for the development of endometritis or metritis and thus 196 
impairs fertility but also animal health in general [44]. Beside infectious diseases, non-infectious 197 
risk factors like dystocia, but also nutritional deficiencies, are listed as causes for the placental 198 
retention albeit the aetiology is not completely understood [44]. Few investigations on proteomic 199 
differences between retained and normal placenta were carried out so far. A review describing the 200 
involvement of extracellular matrix proteins in placenta release was recently published [45]. The 2-201 
DGE reference map for bovine placenta during late pregnancy identified 273 proteins, providing the 202 
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background for studies on molecular mechanism of placenta modification and diseases during late 203 
pregnancy [46]. 204 
Protein differences between retained and normally delivered placentae were studied starting from 205 
tissue obtained from both the fetal and the maternal side of the placenta (i.e. cotyledon villi and 206 
caruncle crypts). Using 1-D and 2-DE, differences between the protein profiles in the two groups 207 
were assessed by means of computer-aided analysis but the identification of specific proteins 208 
remained undone [47]. In a follow-up study, the protein patterns in normal and in retained placentae 209 
were investigated by 2-DIGE [48]. In this study, differentially regulated proteins were identified by 210 
means of MALDI-TOF analysis. Comparisons between fetal healthy/retained and maternal 211 
healthy/retained placentae yielded only five differentially regulated proteins. Albeit preliminary, the 212 
results point to an involvement of RabGTPases, which are known as master regulators of 213 
intracellular trafficking: Ras-related protein Rab-7b was up-regulated only in healthy maternal 214 
placenta, whereas Rab GDP dissociation inhibitor beta was up-regulated in the cotyledons of both 215 
retained and healthy placentae. In addition, short transient receptor potential channel 5 was 216 
identified in caruncles of both retained and healthy placentae, and transforming growth factor 2 217 
was highly abundant in both maternal and fetal parts of retained placenta. The proteins identified in 218 
placental tissues indeed aggrandize the spectrum of relevant pathways to consider in the context of 219 
placental maturation. However, these results were limited to tissue analyses and thus realistic 220 
predictive approaches for retained placentae using body fluids are not coming into reach so far.   221 
The application of metabolomics techniques to metritis and endometritis is still lacking, in both 222 
human and veterinary medicine. 223 
Further studies have to be conducted to distinguish between physiological and pathological protein 224 
and metabolite patterns due to the challenges of parturition and thus to unravel the complexity of 225 
the underlying processes; identifying early indicators for the cow`s ability to cope with the situation 226 




Hypocalcaemia (milk fever)  229 
The requirements for calcium (Ca) increase dramatically towards the end of pregnancy and the 230 
onset of lactation. The Ca content of milk is about 1.2 g/L and a modern dairy cow may produce up 231 
to 60 L per day during peak lactation, resulting in a daily Ca loss of more than 70 g/d. Thus, 232 
metabolic adaptations need to be activated, otherwise the blood concentration of Ca falls below a 233 
critical threshold and clinical and subclinical hypocalcaemia can result [49]. Hypocalcaemia 234 
impacts health, future milk production, and reproductive performance and has been demonstrated to 235 
be linked with compromised immune function; cows with lower blood Ca concentrations within the 236 
first day after calving were more likely to have retained placenta and resulting metritis, and mastitis 237 
[50]. In addition, hypocalcaemia is also associated with metabolic diseases such as left displaced 238 
abomasum, ketosis and fatty liver [51,52]. 239 
Both proteomics and metabolomics provided some molecular insight into pathogenesis of 240 
hypocalcaemia. Proteomic comparisons of plasma samples from dairy cows with or without milk 241 
fever were performed by 2-DIGE, followed by in-gel digestion and MALDI-TOF-MS analysis for 242 
peptide mass fingerprinting of selected protein spots [53]. Out of 23 protein spots found to be 243 
different between the groups, eight were isolated and identified representing five unique proteins: 244 
serpin peptidase inhibitor (angiotensin) and endopin 2B were increased in hypocalcaemic animals, 245 
whereas albumin, fibrinogen beta chain, and IgG heavy-chain C-region (IgG-C(H)) were down-246 
regulated. Interestingly, the study demonstrated also a shift in the electrophoretic mobility of 247 
albumin and angiotensin, suggesting that milk fever not only changes their concentration, but 248 
possibly also their post-translational modification. In another study using weak cationic exchange 249 
protein chips for plasma protein profiling by SELDI-TOF-MS, six proteins were identified in 250 
animals with subclinical hypocalcaemia (average milk yield 30 kg/day) differing from the healthy 251 
controls (average milk yield 28 kg/day) [54]: albumin, fibrinogen alpha chain, amyloid beta A4 252 
proteins and VGF were increased, and apolipoprotein A-II and serum amyloid A proteins were 253 
decreased. In a very recent study [14], serum samples from cows were collected on days -3, 0 and 254 
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+3 relative to calving. According to the Ca serum concentrations the animals were classified as 255 
either healthy or having clinical or subclinical hypocalcaemia. Using samples from day -3, DIGE 256 
and MALDI-TOF MS were used to search for proteins suitable as predictors for postpartum 257 
hypocalcaemia. Five proteins were differentially regulated when comparing cows that developed 258 
clinical milk fever or stayed healthy: Vitamin-D binding protein precursor, paraoxonase, 259 
apolipoprotein A-IV precursor and alpha-1-antitrypsin were decreased, and A2M protein was more 260 
abundant in cows with clinical hypocalcaemia post partum. There was no overlap in these proteins 261 
when comparing healthy cows with those that developed subclinical hypocalcaemia later: compared 262 
to healthy animals, complement C4 precursor, A2M protein, endopin 1 and haptoglobin were 263 
decreased in cows with subclinical hypocalcaemia, and no protein was found to be increased [14]. 264 
The issue of hypocalcaemia was also addressed by assessing the metabolome in serum samples 265 
from hypocalcaemic versus normocalcaemic cows yielding around 30kg milk/day: using a 500-266 
MHz digital (1)H-NMR spectrometer, nine metabolites with differing concentrations between the 267 
groups were found [55]. Glucose, alanine, glycerol, phosphocreatine, and γ-aminobutyrate (GABA) 268 
were decreased, and β-hydroxybutyrate (BHB), acetone, pyruvate, and lysine were increased in 269 
cows with milk fever. The increase of pyruvate is probably also related to the decrease of 270 
phosphocreatinine observed in cows with milk fever, since elevated pyruvate decreases the 271 
production of phosphocreatinine, by inhibiting creatinine-pyruvate kinase at least in humans [56]. 272 
The decrease of phosphocreatine also reduces ATP (adenosine triphosphate) production in muscles, 273 
may partially explain the paresis, ataxia and paralysis that are associated with milk fever. In 274 
addition, the decrease of the inhibitory neurotransmitter GABA may also account for the 275 
neurological symptoms of the disease, e.g. depression and coma. However, the importance of 276 
GABA in the circulation is unknown.  277 
Results provided by proteomics applied to hypocalcaemia are somehow contradictory: for example, 278 
in one study albumin abundance is increased [53], whereas in another the albumin abundance is 279 
decreased [54]. This apparent inconsistencies might be related to the fact that results were obtained 280 
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following two different proteomics techniques (2D-DIGE separation followed by identification with 281 
MALDI-TOF-MS and SELDI-TOF, respectively), rather than to different sampling times (in both 282 
studies sample collection was close to delivery (6 and 24 h, respectively). In view of positive APP, 283 
such as SAA, haptoglobin, complement C4 precursor and alpha-1-antitrypsin being decreased in 284 
hypocalcaemic cows, hypocalcemia might also be related to systemic inflammation. Metabolomics 285 
results are probably more interesting: taken together, the findings reported by metabolomic analyses 286 
indicate a relationship between hypocalcaemia and energy metabolism, rather than a specific 287 
association with Ca metabolism. Although limited to one study [57], metabolomics confirmed in 288 
cows what has been already reported in humans, i.e. that calcium plays a pivotal role in regulating 289 
energy homeostasis. One important finding in this context is that by increasing the Ca2+ 290 
concentration in adipocytes, adipogenesis and a coordinated inhibition of lipolysis were stimulated, 291 
thus demonstrating that Ca is capable of regulating adiposity [58,59]. In dairy cows in which 292 
hypocalcaemia was experimentally induced by intravenous infusion of ethylene glycol tetraacetic 293 
acid (EGTA), a selective Ca-chelator, reduced blood concentrations of insulin and increased levels 294 
of glucose and NEFA were reported, together with reduced phagocytotic and oxidative burst 295 
activity of neutrophils [60]. Even though some of the observed effects in this study might have 296 
partly been caused by the reduced feed intake during EGTA infusion, the findings are in line with a 297 
role of Ca in energy metabolism. Fig. 4 summarizes the differences in metabolome and proteome 298 
between healthy and hypocalcaemic cows. Future omics studies could allow to find possible 299 
explanations for the contradictory results stated above and deepen the insight into the relationships 300 
between hypocalcaemia and energy metabolism. 301 
 302 
Metabolic diseases related to energy metabolism:  303 
During the transition period, nutrients need to be directed towards the growing foetus and the 304 
mammary gland even though feed intake is often depressed around calving and does not increase as 305 
does milk yield. To accomplish an adequate supply of nutrients to foetus and mother, several 306 
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adaptive mechanisms are activated. The main ones are: increasing gluconeogenesis, reducing 307 
peripheral insulin sensitivity and increasing lipolysis. As outlined below, these reactions may also 308 
overshoot and result in the most common metabolic production diseases, i.e. in ketosis and fatty 309 
liver. Ruminants almost entirely depend on gluconeogenesis since glucose from plant carbohydrates 310 
hardly reaches the small intestine due to fermentation in the forestomaches which yields propionate 311 
as the main gluconeogenetic substrate. In particular the mammary gland has a high demand for 312 
glucose to produce lactose, the major osmole in milk. In contrast to other organs, glucose uptake of 313 
the mammary gland is insulin-independent and by decreasing the insulin-sensitivity in skeletal 314 
muscle and adipose tissue, glucose can be drained towards the mammary gland [61]. The increase 315 
in lipolysis provides fatty acids as energy substrates but also for milk fat synthesis; albeit the 316 
contribution of fatty acids from the mobilization of body fat is normally less than 10% of the milk 317 
fatty acids, this share increases proportionally in early lactation with the extent of the energy deficit 318 
[62]. When the rate of lipolysis exceeds the capacity of the liver, fatty liver and ketosis (or 319 
acetonaemia) can occur. With the importance of lipolysis, the central role of adipose tissue comes 320 
into play and indeed many studies including proteomics and metabolomics investigated adipose 321 
tissue in context with peripartum diseases. Oxidation of fatty acids provides acetyl-CoA which is 322 
than condensed with oxaloacetate to form citrate for entering the TCA cycle. However, when 323 
glucose requirements are high, oxaloacetate is increasingly used for gluconeogenesis and thus 324 
acetyl-CoA cannot be completely oxidized but is converted into ketone bodies, mainly acetone, 325 
acetoacetate and BHB. Ketosis, in particular subclinical ketosis, is a common disease in dairy cows 326 
and often concurs with other peripartum diseases such as retained placenta and metritis [63]. Excess 327 
fatty acids can also be re-esterified in the liver and deposited as triglycerides; however, their export 328 
into the circulation is limited based on the low intrinsic capacity for mainly VLDL (very low 329 
density lipoprotein) in ruminants [57,64]. Fatty liver is thus another production disease affecting 330 
many animals at least in mild forms. Taken together the main adaptations to accomplish partitioning 331 
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of nutrients towards foetus and milk are basically known, including the temporal patterns of some 332 
proteins and metabolites during the transition period [65]. 333 
 However, what makes these physiological adaptive mechanisms shift towards pathological 334 
conditions is largely unknown. Using proteomics and metabolomics provides new explanatory 335 
approaches and also potentially also predictors for unfavourable conditions which might be 336 
mitigated if diagnosed early enough. For the latter applied aspects, the use of body fluids, in 337 
particular those that can be collected non-invasively like milk, is certainly preferable; however, 338 
including those tissues that are the major players in energy metabolism, i.e. liver and adipose tissue, 339 
is necessary for clarifying the pathways included and their complex interrelationships.  340 
 Fatty liver: The fatty liver observed in dairy cows has many similarities with non-alcoholic 341 
fatty liver disease (NAFLD) in humans. Several proteomic and metabolomics studies were 342 
published about NAFLD [66–68]. Yet the respective literature on fatty liver in dairy animals is 343 
surprisingly limited. To the best of our knowledge there is only one review about fatty liver 344 
proteomics in farm animals, but it mainly focused on poultry [69]. In dairy cows a proteomic 345 
analysis was carried out in liver obtained from animals (1st lactation,16-201 DIM) fed ad libitum as 346 
compared with feed-deprived cows [70]. Proteins were separated by 2-DE, and those that were 347 
differently regulated were identified by MALDI-TOF. Several pathways related to lipid and to 348 
carbohydrate metabolism were found to be dysregulated. Acyl-CoA dehydrogenase and Acyl-CoA 349 
acetyltransferase 2 were both down-regulated in feed-deprived animals, suggesting decreased fatty 350 
acid degradation and contributing to explain the insurgency of liver disease. The fatty acid binding 351 
protein 1 was also found to be decreased. Other enzymes involved in fatty acid degradation that 352 
were decreased in fed-deprived cows include aldehyde dehydrogenase, which converts fatty acids to 353 
their corresponding aldehydes. On the contrary, sterol carrier protein 2, which catalyzes the 354 
transfer/exchange of cholesterol and phospholipids between membranes, was more abundant in 355 
feed-restricted cows suggesting an increase in lipid trafficking. The decrease of peroxiredoxin-6, 356 
whose main role is to protect against oxidative damages, suggests a possible increase in oxidative 357 
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stress in the ruminant liver during feed restriction. With regard to carbohydrate metabolism, several 358 
enzymes, including 6-phosphofructokinase, enolase1, and triosephosphate isomerase, fructose-359 
bisphosphate aldolase B, sorbitol dehydrogenase and aldehyde dehydrogenase 2 were less abundant 360 
in feed-deprived versus ad libitum fed cows. The corresponding up-regulation of parathymosin, an 361 
inhibitor for glycolytic enzymes, confirms a reduction of glycolysis [71]. Besides, the results 362 
indicated that protein metabolism was also affected by feed deprivation: proteins involved in 363 
protein degradation, such as ubiquitin carboxyl-terminal esterase L3, proteasome 26S subunit, and 364 
protein disulfide-isomerase-related protein 5 were decreased. This result was unexpected, since feed 365 
restriction is believed to result in increased protein degradation. The authors suggested that 366 
downregulating proteins involved in protein degradation might help to protect the liver form 367 
excessive autophagy. In addition, skeletal muscle rather than liver is the greatest labile source of 368 
amino acids for energy needs [72]. However, other “protecting” proteins, such as heat-shock 70 369 
kDa protein 5 (HSPA5), a chaperon, were less abundant in liver of feed-restricted cows. The urea 370 
cycle in particular was dysregulated: proteins, such as arginase-1 and argininosuccinate synthetase, 371 
were up-regulated in feed restriction. Conversely, L-arginine:glycine amidinotransferase and 372 
glutamate dehydrogenase 1, were decreased. Finally, proteins involved in calcium metabolism, such 373 
as regucalcin, annexin IV and calcium binding protein SPEC 2D were increased in the liver of feed-374 
restricted cows. In 2012, a comparison of the liver proteome of cows with either low or high liver 375 
triglyceride (TG) content in early lactation was published [57]. A high liver TG content was found 376 
to be associated with increased oxidation of saturated fatty acids, oxidative stress, and urea 377 
synthesis and decreased oxidation of unsaturated fatty acids, but not with impaired gluconeogenesis. 378 
Aiming to identify hepatic biomarkers for physiological imbalances (PI), the liver proteome of dairy 379 
cows at early and mid lactation (49±22 DIM, average milk yield 42±7 kg/day versus 159±39 DIM, 380 
29±7 kg/day) was determined by means of ITRAQ-based profiling; PI was calculated based on 381 
plasma free fatty acids, BHB, and glucose concentrations and was compared between 6 cows with 382 
greatest and least PI in early and mid lactation, respectively. PI was increased by a 4 day feed 383 
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restriction period and liver biopsies were collected one day before and on day 3 of the feed 384 
restriction [16]. In early lactation, enzymes involved in gluconeogenesis and -oxidation, such as 385 
pyruvate carboxylase and very long chain specific acyl-CoA dehydrogenase, respectively, were 386 
increased in cows with a higher PI indicating increased gluconeogenesis and fatty acid oxidation. In 387 
addition, three enzymes involved in energy metabolism, such as mitochondrial isocitrate NADP+ 388 
(nicotinamide adenine dinucleotide phosphate)-dependent dehydrogenase, glycine N-389 
acyltransferase and UDP-glucose 6-dehydrogenase were decreased, partially explaining the 390 
molecular background of PI. By increasing nutrient restriction, thus aggravating the status of PI, the 391 
increasing demand of energy coupled with a decrease of anti-oxidant defense is confirmed by an 392 
upregulation of mitochondrial trifunctional protein, subunit α, enoyl-CoA hydratase and pyruvate 393 
carboxylase and downregulation of glutathione S-transferase Mu 1, manganese superoxide 394 
dismutase, aldehyde oxidase, and glycine N-acyltransferase. Proteins related to apoptosis (14-3-3 395 
protein β/α), and mobilization and targeting of fatty acid (liver fatty acid binding protein) were also 396 
decreased. 397 
During mid lactation, before feed restriction, PI increased the amount of proteins involved in ketone 398 
biosynthesis, such as alcohol dehydrogenase 4 and alcohol dehydrogenase NADP+, and in TCA 399 
cycle, including dihydrolipoamide dehydrogenase 2 and methylmalonate-semialdehyde 400 
dehydrogenase. Again, proteins involved in antioxidant defense and CO2 transport, such as carbonic 401 
anhydrase 3 were decreased. After increasing PI by means of nutrient restriction, the upregulation 402 
of proteins involved in fatty acid oxidation, such as acetyl-CoA oxidase 2, acyl-CoA-binding 403 
protein and carnitine O-palmitoyltransferase 2 was even more pronounced. Proteins involved in 404 
ketone biosynthesis, such as acetyl-CoA acyltransferase were increased as well. Consistent with 405 
changes related to PI during early lactation, the experiment amplification of PI decreased proteins 406 
involved in antioxidant defenses, such as peptide methionine sulfoxide reductase, Glutathione S-407 
transferase A1, and carbonic anhydrase 3 . Proteins involved in amino acid metabolism, such as 408 
peptide methionine sulphoxide reductase and ornithine carbamoyltransferase, and fatty acid 409 
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oxidation, such as short-chain specific acyl-CoA dehydrogenase and hydroxyacyl-CoA 410 
dehydrogenase, were also downregulated. Beside the identification of potential biomarkers for 411 
different degree of PI, the study of Moyes and coworkers [16] provided a better understanding of 412 
the molecular background of liver diseases during PI, as shown by the downregulation of proteins 413 
related to anti-oxidant defense, which might be responsible for the increasing cellular damage. For 414 
aldehyde dehydrogenase and HSP70, relationships with NAFLD in rats and in humans, 415 
respectively, were identified earlier [73,74]. 416 
Metabolomics approaches were also applied to study the pathogenesis of and the search for 417 
biomarkers in fatty liver disease. A recent review highlighted the state of the art in human and 418 
laboratory animal metabolomics investigations on fatty liver diseases [75]. Several studies 419 
addressed the modifications induced by the development of fatty liver disease in dairy ruminants by 420 
means of metabolomic techniques. A serum metabolomic profile using a triple quadrupole 421 
spectrometry identified a total of 29 metabolites which allowed to discriminate healthy cows from 422 
animals with hepatic lipidosis [23]. The experimental design included animals with different ranges 423 
of hepatic lipidosis, ranging from low, medium to severe grade. Some animals also displayed, in 424 
addition, other diseases, such as displaced abomasum, bronchopneumonia, retained placenta, and 425 
mastitis. Six phosphatidylcholines were identified as promising predictive biomarkers of hepatic 426 
lipidosis. The other discriminating metabolites included amino acids, such as glycine and 427 
glutamine, sphingomyelins and hydroxy-sphingomyelins and other phosphatidylcholines, but could 428 
only discriminate the three unhealthy groups from the healthy animals. Beside their possible use as 429 
biomarkers, the finding that the phosphatidylcholine asset is modified during lipidosis is interesting: 430 
phosphatidylcholines are precursors of hepatic triacylglycerols [76], and can decrease peripartum 431 
due to an increased triacylglycerol production [77–79]. Assembly and secretion of lipoproteins 432 
require the contribution of phosphatidylcholines. By limiting the hepatic synthesis of lipoproteins, 433 
which export fatty acids from hepatocytes, the decrease of phosphatidylcholine content may 434 
aggravate the accumulation of lipids in the liver [80]. 435 
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A parallel study focusing on the plasma lipidome also drove to similar conclusions [81]. The 436 
investigation was carried out on animals with different grades of fatty liver, displaying weak, 437 
medium and severe disease. The lipid extracts were profiled by means of separation with ultra 438 
performance LC and identification with LC-MS. The study confirmed that phosphatidylcholines are 439 
reduced in animals with medium and severe fatty liver disease. Five bile acids were decreased as 440 
related to increased severity of fatty liver. Remarkably, the insurgency of fatty liver diseases was 441 
positively correlated to the presence of Resolvin E1 and palmytoil-ethanolamine. Resolvin E1 is 442 
synthesized from ω-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and 443 
docosahexaenoic acid (DHA), and is an anti-inflammatory lipid mediator[82,83][82] [83]. Also 444 
palmytoil-ethanolamine is an endogenous amide with anti-inflammatory activity [84]. It is known 445 
that metabolic diseases such as fatty liver also induce an inflammation [85]. The study of Gerspach 446 
and coworkers [81], therefore, confirmed that anti-inflammatory pathways are activated during fatty 447 
liver disease. One estrogen metabolite, not further specified, was found to discriminate between 448 
mild or strong and weak fatty liver in the same study.  449 
A novel approach relying on (1)H-NMR investigated the metabolome in fatty livers of 171 Holstein 450 
cows [86]. The main advantage of this technique in the metabolomic field is that it can provide a 451 
profile of proton-containing, low-molecular-weight metabolites, starting from a limited amount of 452 
sample [87]. Plasma and liver tissue samples from animals with fatty liver disease (16.31±4.30 453 
DIM, average milk yield 28.32±4.73 kg/day) and healthy animals (15.5±6.02 DIM, average milk 454 
yield 30.75±3.7 kg/day) were included in the study. As expected, plasma from animals with fatty 455 
liver disease had increased BHB, isobutyrate and acetone concentrations. The amino acids glycine, 456 
valine, trimethylamine-N-oxide, and citrulline were also increased. Conversely, other amino acids 457 
such as alanine and asparagine were decreased. Glucose, GABA, glycerol, and creatinine were 458 
decreased as well. The decrease of alanine and asparagine is consistent with their role as 459 
gluconeogenic amino acids, since both can enter the TCA cycle to generate glucose during an 460 
energy-deficient status. The finding that trimethylamine-N-oxide and citrulline are increased what is 461 
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usually accompanied by oxidative stress and liver damage, corresponds to what has been 462 
demonstrated in other species, such as mice [88] and humans [89].  463 
Ketosis: to extend the understanding of the pathogenic effects of ketosis, protein 464 
modifications were determined by using 2-DE coupled with MALDI-TOF for comparing the 465 
proteomic profiles in liver from healthy and ketotic cows [90]. Several metabolic pathways were 466 
found to be altered in ketosis. Structural proteins, such as myosin related proteins (myosin light 467 
chain for example, and tropomyosin) and MGC128326 were significantly up-regulated in liver from 468 
cows with ketosis. As shown by the increased number of isoforms, post translational modifications 469 
related to ketosis were assumed. Myoglobin was also more abundant, suggesting an activation of 470 
oxidative stress defense pathways, which is confirmed by the upregulation of proteins belonging to 471 
the peroxiredoxin families, such as peroxiredoxin – 5 and -6, glutathione S-transferase alpha-1, 472 
flavin reductase and sulfotransferases, all of them fulfilling anti-oxidant activities. As expected, 473 
proteins related to gluconeogenesis, such as α-enolase, were also increased during ketosis. The list 474 
of proteins that were decreased in ketotic liver included also proteins involved in fatty acid 475 
oxidation, such as acetyl-CoA acetyltransferase 2 and 3-hydroxyacyl-CoA dehydrogenase, 476 
suggesting a further possible relationship between ketosis and lipidosis: as a consequence of the 477 
decreased ability to utilize them, fatty acids accumulate in liver cells, contributing to the 478 
development of hepatic lipidosis. 479 
Beside liver and plasma, the difference of proteomic profiles in animals with ketosis were also 480 
explored in urine using SELDI-TOF techniques [91]. Samples were collected 7 – 28 DIM from two 481 
groups of animals, one affected by clinical ketosis and the other from healthy cows, with a milk 482 
production of 9625 kg/year. The urinary profile of animals with ketosis showed a decrease for 11 483 
proteins, most of them involved in the inflammatory response, such as fibrinogen, C1 inhibitor, 484 
osteopontin, also hepcidin and human neutrophil peptides 1-3. Interestingly, also proteins associated 485 
with the neuron function, such as VGF (non-acronymic) protein and amyloid precursor protein, 486 
were decreased in the animals with ketosis as compared with the control group. Proteins related to 487 
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lipid metabolism, as well as inflammation, were also decreased during ketosis, namely SAA and 488 
apolipoprotein C-III, indicating a change in lipid metabolism during ketosis. Two other proteins, i.e. 489 
transthyretin, a transport protein, and cystatin C, a protease inhibitor, were also decreased. 490 
Fibrinogen, hepcidin and SAA are acute phase proteins [92] and their concentration is supposed to 491 
increase during an inflammatory status. Targeted assessments of acute phase proteins in blood have 492 
shown increased concentrations of inflammatory markers in ketotic cows. Thus the finding of 493 
decreased concentrations of SAA in urine of ketotic cows is opposing the situation in blood and 494 
deserves further investigation. The proteins differentially regulated in liver and urine of cows with 495 
ketosis as compared to healthy animals are presented in Fig. 5. 496 
More than proteomics, it is metabolomics that contributed to address the changes in biological 497 
fluids during ketosis. A NMR-based metabolomic analysis on milk from animals with ketosis was 498 
carried out during a time course study on 264 high yielding dairy cows with an average milk yield 499 
of 32.8 ± 4.7 kg energy corrected milk/day [93]. Milk samples were collected weekly for 5 weeks 500 
and once again 6 months post partum. NMR spectroscopy was carried out, and presented evidence 501 
that high milk glycerophosphocholine (GPC) levels and high ratios of GPC to phosphocholine (PC) 502 
during the first four weeks of lactation, and GPC at mid lactation, could provide reliable biomarkers 503 
for the development of ketosis. Although milk provides an ideal substrate for metabolomic analysis, 504 
being collected routinely and non-invasively, more studies were carried out on plasma metabolome, 505 
which, conversely, yields a higher amount of potential biomarker metabolites. A metabolomic 506 
approach using GC/MS techniques analysed the differential plasma metabolomes of dairy cows 507 
with clinical (12 ± 5 DIM, 32.1 ± 7.8 kg milk/day) and subclinical ketosis (14 ± 6 DIM, 35.0 ± 7.2 508 
kg milk/day), as compared with healthy animals (16 ± 6 DIM, 37.0 ± 6.2 kg milk/day) [94]. The 509 
study revealed that the metabolomes of animals with subclinical and clinical ketosis were mostly 510 
identical, whereas 25 potential biomarkers were found between animals with ketosis, both clinical 511 
and subclinical, when compared with healthy animals indicating that several biochemical pathways 512 
were modified. The nine metabolites decreased during ketosis suggested a decrease in 513 
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gluconeogenesis in affected animals, and a parallel activation of the pentose-phosphate pathway. A 514 
decrease of ribitol levels, related to riboflavin deficiency, and vitamin C, may increase the oxidative 515 
stress. The decrease of lactic acid and L-alanine, which are both gluconeogenetic precursors, 516 
suggested a close relationship between ketosis and carbohydrate metabolism, as a consequence of 517 
hypoglycaemia and lack of precursors of gluconeogenesis. Sixteen metabolites were increased in 518 
animals with ketosis. As expected, this list included ketone bodies, and fatty acids, such as BHB, 519 
palmitic acid, heptadecanoic acid, stearic acid, trans-9-octadecenoic acid, myristic acid, cis-9-520 
hexadecenoic acid, confirming also the mobilization of adipose tissue. Amino acids were also found 521 
to be increased, namely L-isoleucine and a catabolic product of lysine, 2-piperidinecarboxylic acid, 522 
two amino acids involved in ketogenesis, and glycine, suggesting an increase of proteolysis needed 523 
to fuel gluconeogenesis. The study confirmed BHB acid as gold biomarker for ketosis, and 524 
suggested cis-9-hexadecenoic acid as novel biomarker for clinical ketosis, and an indicator of fat 525 
mobilization. Plasma metabolic profiling from cows affected by clinical ketosis was determined 526 
with two other different techniques, namely LC/MS and (1)-NMR. In a study whose experimental 527 
design was very similar to that of Zhang and coworkers [94] plasma metabolomics of cow with 528 
clinical and subclinical ketosis was determined by means of 1H-NMR [95]. A total of 25 529 
metabolites were found to be dysregulated as a consequence of various stages of the disease, and as 530 
compared with healthy animals. Amino acids including histidine, glutamic acid, glutamine, lysine 531 
and phenylalanine, together with lactate and glucose, were decreased during ketosis. Amino acids 532 
such as alanine, proline and tyrosine decreased only in clinical ketosis, as well as LDL and VLDL. 533 
As expected, metabolites related to biosynthesis of ketone bodies, such as BHB, N-534 
Acetylglucosamine, acetate, acetoacetate and acetone were increased in ketotic cows. Glycine, 535 
leucine, isoleucine and valine were increased in clinical ketosis only. A last study, this time focused 536 
on the differences in metabolomes between Holstein Friesian cows, 12 - 16 DIM and 18 - 21 kg 537 
milk /day, affected with clinical ketosis or being healthy, was carried out by means of LC/MS [96]: 538 
aminoacyls such as valine, glycine, and lipids, such as glycocholic, tetradecenoic and palmitoleic 539 
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acid, were increased in clinical ketosis, whereas other amino acids, such as arginine, leucine, 540 
isoleucine, tryptophan and lysine decreased. Aminobutyric acid, creatinine, undecanoic acid and 541 
norcotinine were decreased as well. Consistent with previous reports, obtained with different 542 
metabolomic techniques, the study from Li and coworkers [96] confirmed that amino acids are 543 
affected during ketosis: e.g. glycine was increased whereas lysine was decreased. 544 
 545 
Pathophysiological alterations in the proteome and metabolome of adipose tissue related to 546 
the transition period 547 
Adipose tissue fulfills a dual role: it regulates energy storage by storing and releasing fatty acids, 548 
and is a major endocrine gland, capable of modulating metabolism by secreting hormones and 549 
adipokines [97]. As mentioned earlier, the transition from late pregnancy to early lactation is 550 
accompanied by an increased rate of lipolysis. Furthermore, adipose tissue can regulate, by means 551 
of modifying its adipokine asset, the development of major metabolic changes such as insulin 552 
resistance or sensitivity [7,61,98]. 553 
The proteome of subcutaneous adipose tissue from cows classified as either insulin-resistant or 554 
insulin-sensitive according to phosphorylation of protein kinase B (AKT) in this tissue was 555 
characterized by quantitative shotgun proteomics (nanoLC-MS/MS) [99]. Adipose tissue biopsies 556 
were collected 17 days before and 3 – 5 days after calving. From 586 proteins detected, 143 were 557 
differentially regulated in prepartum versus postpartum tissue. Several functions, such as those 558 
related to lipid metabolism, including fatty acid metabolism, the esterification of lipids and 559 
oxidation of fatty acids, appeared as changed. The proteins whose abundance was decreased after 560 
calving included fatty acid synthase, complement C3, annexin-A1 and acyl-CoA desaturase. 561 
Comparing insulin-resistant and insulin-sensitive subcutaneous adipose tissue yielded 111 proteins 562 
that were differentially regulated. Most of them (a total number of 106) were more abundant in the 563 
insulin-resistant state, whereas only five were decreased. Insulin resistance was associated with a 564 
dysregulation of pathways related to energy and lipid metabolism, including gluconeogenesis and 565 
23 
 
glycolysis, signaling mediated by 14−3−3, TCA cycle, ERK/MAPK signaling, lipid accumulation, 566 
release and lipolysis. Inflammatory responses, such as leukocyte migration and proliferation of T 567 
lymphocytes, were also activated in insulin-resistant adipose tissue. 568 
During the transition period, adipose tissue may also react to stress related to environmental factors, 569 
such as heat. A label-free, quantitative shotgun proteomics (nano-LC-MS/MS) approach 570 
investigated the effects of seasonal heat stress on the adipose proteome, aiming to highlight 571 
biomarkers of heat stress on late pregnant cows during summer heat stress (average milk yield 33.8 572 
kg/day) as compared to the winter season (38.2 kg/day) [100,101]. The proteome in subcutaneous 573 
adipose tissue biopsies obtained 14 day before calving yielded a total number of 107 out of 1495 574 
proteins identified that were differentially abundant between summer and winter. The pathways that 575 
were found to be modified included the Keap1-Nrf2 pathway which is the major regulator of 576 
cytoprotective responses to oxidative and electrophilic stress [102], such as STIP1 and ubiquitin-577 
conjugating enzyme E2 K, which were increased in summer, and GSTM1, microsomal GST 1, 578 
(MGST1), GST Mu 3 (GSTM3), ferritin heavy chain and MAP2K1 which were decreased. The 579 
acute phase response was also modified. In particular, albumin, hemopexin, serotransferrin, AGP, 580 
apolipoprotein A-II, α-2-HS-glycoprotein, C-reactive protein and MAP2K1 were decreased in 581 
summer, whereas the abundance of the von Willebrand factor and fibrinogen α chain was increased. 582 
Protein related to the farnesoid X receptor (FXR)[103], which is a member of the nuclear family of 583 
receptors in control of numerous metabolic pathways, and, jointly with retinoid X receptor (RXR), 584 
plays a crucial role in linking bile acid productions with lipoprotein, lipid and glucose metabolism, 585 
were also modified, as well as proteins belonging to Liver X receptor/RXR pathways [104], whose 586 
function is to regulate cholesterol, fatty acid, and glucose homeostasis. The finding of this study 587 
provided the evidence that heat stress has a local impact on adipose tissue in late pregnant cows, 588 




Pathophysiological alterations in the proteome and metabolome of skeletal muscle related to 591 
the transition period 592 
Several studies point to the importance of amino acid metabolism in context with the 593 
pathophysiological changes related to the metabolic challenges of the transition period. An 594 
increased need for amino acids results from fetal growth and milk protein synthesis but is also 595 
related to the use of amino acids for generating energy by direct oxidation or as precursors for 596 
gluconeogenesis. The dogma that amino acids are significant contributors to hepatic 597 
gluconeogenesis has recently been revised based on quantitative data on the uptake of amino acids 598 
by the liver; only alanine remains in the list of quantitatively important gluconeogenetic amino 599 
acids [105]. However, there is also an increased need for amino acids for positive acute phase 600 
proteins [106–108] which show a distinct and typical peak around calving [39].The biggest labile 601 
source for amino acids in the body is skeletal muscle, but the number of proteomics or 602 
metabolomics studies actually addressing this tissue in context with transition cow is very limited. 603 
Kuhla and coworkers [105] used 2-DE and MALDI-TOF-MS on muscle biopsies collected in week 604 
-3, 0, +2 and +4 relative to calving. In total 43 differentially regulated muscle protein spots were 605 
identified throughout the periparturient period. In early lactation, abundance of cytoskeletal proteins 606 
and enzymes involved in glycogen synthesis and in the TCA cycle was decreased, whereas proteins 607 
related to glycolysis, fatty acid degradation, lactate, and ATP production were increased. 608 
Metabolomic investigations of skeletal muscle in transition cows are only at the verge of being 609 
published: in view of several abstracts presented at the International Animal Science and Dairy 610 
Science meeting in 2016 and 2017, several publications on this topic can be expected [109–111]. 611 
 612 
Associations of proteomes and metabolomes with productive life span, energy balance and 613 
feed regulation 614 
Several studies focusing on the metabolic situation during the transition period in general rather 615 
than on specific production diseases also contributed to our understanding on the pathophysiology 616 
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of the underlying adaptive responses. Aiming to find biomarkers for any kind of production 617 
diseases relevant for transition dairy cows, a quantitative targeted metabolomics approach was used 618 
[21]. Plasma collected at 4 time points from 4 weeks prepartum to 4 weeks post partum from 12 619 
cows of which 6 developed multiple peripartum diseases, including laminitis, mastitis, metritis and 620 
retained placenta whereas the other 6 cows remained healthy was compared. The study identified 621 
five plasma metabolites that could be related to periparturient diseases: carnitine, valerylcarnitine, 622 
propionyl carnitine, lysophosphatidylcholine acyl C18:2 and lysophosphatidylcholine acyl C14:0 623 
were increased in animals that developed peripartum related diseases as compared with healthy 624 
controls as early as 4 weeks before parturition. Two phosphatidylcholines, namely 625 
phosphatidylcholine acyl-alkyl C42:4 and phosphatidylcholine diacyl C42:6, were increased 1 week 626 
before delivery. Carnitine, lysophosphatidylcholine acyl C18:2 and lysophosphatidylcholine acyl 627 
C14:0 were increased 1 week postpartum as well, whereas carnitine was decreased after 4 weeks. 628 
These results are remarkable, since they highlighted the possible use of three metabolites, namely 629 
carnitine, propionyl carnitine, and lysophosphatidylcholine acyl C14:0 as potentially predictive of 630 
peripartum-related diseases up to 4 weeks before delivery [21,96]. 631 
The occurrence of production diseases exerts profound effects on productive life span since 632 
continued disorders like decreased fertility may result which in turn give reason to premature 633 
culling. Even in case of non-ouvert disease, a metabolic predisposition for the risk of leaving the 634 
herd prematurely might exist. Huber and colleagues [22] applied targeted metabolomics but also 635 
“classical” variables (e.g. insulin, free fatty acids, BHB) to search for factors predisposing for 636 
shorter or longer productive lifespan in 19 cows that remained apparently healthy during the first 637 
100 days of lactation. Eight of these cows left productive life within the current lactation due to 638 
various health and fertility problems and 11 cows finished the current lactation without any signs of 639 
clinical illness. Long-chain acylcarnitines and biogenic amines were found to be associated with 640 
extended productive life span. These metabolites are mainly secreted by the liver and depend on the 641 
functionality of hepatic mitochondria. The concentrations of biogenic amines and some 642 
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acylcarnitines differed already before the onset of lactation thus indicating their predictive potential 643 
for continuation or early ending of productive life. 644 
Using milk samples from cows with great differences in energy balance, achieved by varying the 645 
length of the dry period, Lu and coworkers [112] applied untargeted metabolomics and proteomics 646 
techniques, i.e. as NMR in milk serum and milk lipids as well as FASP Dimethyl Labeling-647 
NanoLC-Orbitrap-MS/MS on milk fat globule membrane proteins. They found that a severely 648 
negative energy balance was related to greater concentrations of acute phase response proteins, 649 
unsaturated fatty acids, and galactose-1-phosphate. In contrast, the concentrations of cholesterol, 650 
cholesterol synthesis-related proteins, and stomatin were increased in improved energy balance. The 651 
appropriateness of using milk proteomic and metabolomic data to draw conclusions not only about 652 
milk quality but about the individual cow’s health situation is of outstanding importance. Using 653 
NMR techniques in routine milk recordings is aimed at applying such information in herd health 654 
management programs or for breeding purposes. Maher and co-workers [113] compared the 655 
metabolic profiles from blood and from milk samples obtained from Holstein cows via 1H NMR 656 
methods and statistical heterospectroscopy. The authors summarized their results as being 657 
confirmative for milk being a distinct metabolic compartment with a metabolite composition largely 658 
not influenced by plasma composition under normal circumstances. Similarly, Ilves and coworkers 659 
[114] reported that there is only little correlation between the composition of the metabolomes in 660 
milk and in blood. However, the group of Maher [113] found trimethylamine and dimethylsulfone, 661 
both originating from rumen fermentation, being correlated across both body fluids, indicating that 662 
measuring these substances in either body fluid might allow to evaluate rumen function. Taken 663 
together, omics techniques provide a detailed view on a great number of metabolites or proteins and 664 
thus enable to also consider additional factors previously not considered. The knowledge of the 665 
factors influencing or indicating the metabolic situation and productive lifespan of dairy cows can 666 
thus be deepened. Nevertheless, extrapolating results from a given experimental design, body fluid 667 
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or tissue, and performance level of cows likely has its limitations when conditions e.g. timing of 668 
samples relative to physiological status, are different.  669 
 670 
Proteomics during laminitis. 671 
Laminitis (Pododermatitis aseptica diffusa), also known as sole-haemorrhage, is an inflammation of 672 
the laminar corium of the hoof. Cow laminitis accounts for 41% of cases of lameness [115] and is 673 
most prevalent around day 50 to day 100 of lactation [116]. It is thus not a typical disease for early 674 
lactation as the other diseases included in this review, but the course of the preceding reactions 675 
during the transition period might form predisposing elements for developing laminitis. Related to 676 
laminitis are several claw horn lesions, such as white line disease and ulcers of the sole. Metabolic 677 
diseases, in particular acidosis, both clinical and subacute ruminal acidosis (SARA) are regarded as 678 
underlying cause of laminitis [117], although the pathogenesis is not fully understood. The digestive 679 
disorder SARA is found in up to 19% of early lactation dairy cows as well as 26% of mid-lactation 680 
cows, and is related to diets with high portions of concentrate. Increasing the portion of concentrate 681 
is a common strategy to improve the energy supply for cows, but there is a risk for shifting the 682 
rumen microbiota toward increased lactate production and thus acidification of rumen content 683 
which may result in increased histamine secretion and thereby also affect the claw capillaries [118]. 684 
However, the causes of laminitis and associated claw horn lesions are multi-factorial in nature 685 
[119,120]. 686 
In equine medicine, laminitis can be induced by feeding and using such models several omics 687 
studies have been carried out to unravel the pathogenesis of the disease, or to look for predictive 688 
biomarkers [121,122]. As a preliminary step to unravel the changes in plasma of dairy cows 689 
affected from laminitis, a proteome analysis carried out by 2-DE coupled with MALDI-TOF 690 
identification of differentially regulated proteins between animals with spontaneously occurring 691 
clinical laminitis and healthy animals used as controls was carried out [123]. A semi-quantitative 692 
analysis of the 2-DE gels revealed that 16 proteins were differentially regulated between the two 693 
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groups of animals, of which 12 were more abundant in laminitis, and 4 were decreased, as 694 
compared to healthy animals. Proteins involved in inflammation and in defensive mechanisms were 695 
increased during laminitis, namely complement component C9, haptoglobin and conglutinin, as 696 
well as apolipoprotein A-IV, and apolipoprotein A-I, which are also involved in inflammatory 697 
reaction, but also in lipid metabolism, together with 3-hydroxy-3-methylglutaryl-CoA reductase. 698 
The group of more abundant proteins includes also zinc finger protein 300-like, transmembrane 699 
protein TMP10, isocitrate dehydrogenase, and serum albumin. The upregulation of serum albumin 700 
is remarkable, and apparently in contradiction with the behaviour of albumin during acute 701 
inflammation. Serum albumin is a negative acute phase protein [92,124] and, therefore, its serum 702 
concentration decreases during acute inflammation, as it has been demonstrated also in laminitis 703 
[125]. It must be said that the upregulation of albumin is hardly demonstrable in the context of the 704 
experimental design of the study, on the background that the samples were analyzed after depletion 705 
of abundant proteins, such as albumin and immunoglobulins, to decrease the dynamic range of the 706 
samples. Besides, it has been demonstrated that albumin may be regarded as a local positive acute 707 
phase protein during mastitis, being up-regulated by epithelial cells of the mammary gland [126]. 708 
The proteins that were less abundant in plasma from animals affected by clinical laminitis include 709 
two members of complement pathways, namely C4BP, which is an inhibitor of complement, and 710 
Complement C9 precursor, and Glycerol-3-phosphate dehydrogenase 1-like protein, and Ectoderm-711 
neural cortex protein 1, which is an actin-binding protein playing a role in the oxidative stress 712 
response. The number of proteomics studies on bovine laminitis is yet too limited to draw final 713 
conclusions about the pathogenesis. Nevertheless, proteomics results confirmed the development of 714 
a pro-inflammatory loop, as demonstrated by the upregulation of inflammation-related pathways, 715 
and a converse down-regulation of anti-inflammatory factors, as demonstrated by the decrease of 716 
C4BP. The increase of complement C9 and the parallel decrease of complement C9 precursor 717 
suggests that the complement pathway is activated, since the C9 precursor is less abundant, likely to 718 
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produce the active C9 protein. To the best of the knowledge of the authors, no metabolomics studies 719 
on cow laminitis were carried out to date. 720 
 721 
Proteomics and metabolomics in transition period related diseases: gaps and perspectives 722 
The main features of the metabolic derangements occurring in the typical production diseases of 723 
dairy cows that are related to the transition from pregnancy to lactation are basically known since 724 
several years. In particular for the metabolic diseases, overshooting lipolysis and ketogenesis were 725 
identified as aetiologic key elements. However, the knowledge of the molecular basis of successful 726 
versus compromised adaptation to the metabolic challenge of early lactation is still incomplete. 727 
Omics technologies such as proteomics and metabolomics provide important tools to close this gap 728 
in understanding the pathophysiology and also hold some promise for developing biomarkers.  729 
Understanding the pathophysiology: beside transcriptomics, proteomics applied to adipose 730 
tissue, for example, has evidently contributed to a huge advancement in the knowledge of the 731 
involvement of this tissue in the development of transition-related diseases [127]. Proteome maps 732 
have been established for several biological fluids and tissues in cattle [128], and the amount of the 733 
literature available on cow proteomics and metabolomics is steadily growing, as shown in Fig. 6. 734 
Nonetheless, although increasing exponentially during the last few years, the application of 735 
proteomics and metabolomics in veterinary and animal science is lagging behind those in human 736 
medicine [11], and several gaps have yet to be covered. A wider application of proteomics 737 
techniques in bovine peripartum-related diseases is hampered by the lack of tools to validate the MS 738 
findings. The availability of the bovine genome [129] will allow for a very precise identification of 739 
selected proteins and is poised for closing this gap. Moreover, the complete annotation of the 740 
genome provided a full application of bioinformatics tools to characterize the pathways where these 741 
proteins are involved in. Yet, for a biological validation of proteins identified at different abundance 742 
in proteomics approaches, the options are limited to the use of antibodies in immunoassays (e.g. 743 
ELISA) or in Western blotting. For both approaches, the specificity of the antibodies is limiting, 744 
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and species determined differences in the amino acid sequence might hamper the applicability of 745 
antibodies developed against the target protein in different species. Besides, the performance of 746 
antibodies in different methodological set-ups can differ. The quantitative power of immunoassays 747 
like ELISA is usually good, but developing a valid ELISA system is laborious and time consuming. 748 
In Western blotting, the effort of setting up a system with a working antibody is often considered as 749 
faster, but when aiming to work quantitatively, comprehensive validation is also required and 750 
determining differences as low as 2 to 4-fold may remain impossible [130].  In view of these 751 
limitations, assessing the matching mRNA concentration, preferably from identical sample for 752 
validating results from proteomics is often used as “biological validation”.  However, the 753 
abundance of mRNA may not correspond to the abundance of the respective protein [131] and 754 
therefore relying on the direct, absolute correlation between protein and mRNA levels is hardly an 755 
adequate validation measurement [132]. Nevertheless, albeit being far from perfect, in many cases 756 
quantifying the mRNA abundance remains the only approach available [131], but is further limited 757 
to cells and tissues, where both mRNA and proteins are accessible. When proteomics is carried out 758 
in biological fluids, such as saliva, urine and blood serum, only protein but not mRNA material is 759 
available. Nonetheless, the growing economic interests in producing antibodies and also assays 760 
specific for various animal species, including cattle, might cover this gap in the near future. The 761 
validation of metabolomics results is easier, there is no species issue and expectedly the comparison 762 
between results obtained via MS-based targeted metabolomics with classical assays yielded good 763 
correlations. For example, in a study in which 17 free amino acids were measured in 54 dairy cows’ 764 
sera both via classical methods or via a target metabolomics approach [133] the concentrations 765 
obtained by the two methods were all correlated (P < 0.0001), with an average r-value of 0.82 ± 766 
0.14 (mean ± SD; Dr Hassan Sadri, personal communication). In non-targeted metabolomics, the 767 
ongoing improvement of the livestock metabolome database (LMBDB, available at 768 
http://www.lmdb.ca), will facilitate future untargeted metabolomics studies by increasing the 769 
number of identified metabolites. The main gap to be covered includes metabolite coverage and 770 
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their quantification, however improving the data set and information included in the livestock 771 
metabolome database (LMBDB, available at http://www.lmdb.ca), will facilitate future untargeted 772 
metabolomics studies. For NMR-based approaches, there is a large variability of reference methods 773 
used for calibration, and thus standardizing the methods used within and across countries is still a 774 
major challenge [134]. Moreover, albeit the application in milk is attractive in terms of being non-775 
invasive and combined with well-established routine assessments of macro nutrients in milk, it 776 
should be kept in mind that there is only little correlation between the composition of the 777 
metabolomes in milk and in blood [114].  778 
Standardization and comprehensive reporting of experimental conditions and animal characteristics 779 
is a basic requirement but is often incomplete, albeit respective guidelines are available, at least in 780 
laboratory animals [135]. This is a general shortcoming that, albeit not specific for proteomics and 781 
metabolomics studies, is of particular importance for omics techniques due to the snapshot character 782 
of the results generated. In large animals as dairy cows, standardization of experimental conditions 783 
and animals is close to impossible but important information such as age, lactation number and 784 
stage, body condition, diet composition and feeding regimen as well as detailed description of 785 
sampling procedures and timing relative to physiological state are sometimes missing. Given the 786 
background that the development of metabolic diseases in ruminants is strongly related to the 787 
nutrient requirements which in turn depend mainly on the level of milk production, the need for 788 
reporting milk yield and composition for an appropriate interpretation of data is obvious.  789 
Applying proteomics and metabolomics to the complex of transition period-related diseases for 790 
elucidating the underlying pathophysiological processes is beneficial and allows for developing a 791 
holistic imagination but also a faster progress in research. Diseases apparently not related, such as 792 
fatty liver, hypocalcaemia, ruminal acidosis and laminitis, could be identified as being associated 793 
not only from epidemiology data but also for what concerns their molecular backgrounds. Examples 794 
for newly emerging disease associated pathways from proteomics and metabolomics comprise the 795 
relationship with energy status in hypocalcaemia [57], the involvement of RabGTPases in retained 796 
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placenta [48] or the observation of decreased cystatin concentrations in urine from ketosis-affected 797 
cows [43]. In addition, the concept of NEFA oxidation rather than lipolysis alone influences the 798 
adaptive capability to the metabolic challenge of early lactation, was substantially supported by the 799 
acyl-carnitine data from metabolomics [22,96] but also from proteomics [16]. Applying omics 800 
techniques distal from transcriptomics is also particularly promising in terms of quantitative aspects 801 
since the relative importance of pathways can be evaluated by the flux changes and thus may allow 802 
for identifying molecular targets most promising for prophylactic, metaphylactic or therapeutic 803 
interventions. For making more efficient use of the analytical techniques available for 804 
understanding the adaptive responses in dairy cows, a systemic approach is required. Integration of 805 
different omics techniques, namely metabolomics, proteomics and transcriptomics in the same 806 
study, will help to produce a holistic and comprehensive interpretation of multi-omics data. Hereby 807 
production data and, if available, genotype information, should be combined for providing an 808 
integrated network of the single elements, the knowledge of which could yield a level of 809 
information higher than the sum of individual parts. It must be said that this gap may be difficult to 810 
bridge, given the shortage of funding available to livestock research as compared to medical studies. 811 
Nevertheless when balancing the amount of information provided from metabolomics and 812 
proteomics against the one from  classical assays for the different targets, the omics approaches, in 813 
particular those where no further biological validation is required as in case of metabolomics, might 814 
nevertheless work out superior in terms of costs.   815 
Development of Biomarkers: Selecting biomarker candidates from proteomes and 816 
metabolomes that show great differences when comparing diseases cows against healthy controls 817 
and that can be assessed in body fluids may yield predictive and diagnostic tools. However, such 818 
biomarkers will be based on quantitative results since none of the candidates will be found in 819 
healthy or in diseased state only. Proteomics studies do mostly not provide truly quantitative data, 820 
but refer to trends, e.g. an increase or a decrease as compared to internal standards. Applying 821 
proteomic techniques to metabolic diseases has not provided any robust and consistent list of 822 
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biomarkers so far, although it has shed some light into the pathogenesis of many transition-period 823 
related diseases. More than proteomics, metabolomics contributed more to discovering potential 824 
biomarkers. As mentioned above, carnitines emerged as potential biomarkers for metabolic diseases 825 
related to transition period [21,22,96,109]. When considering the application of biomarker 826 
candidates it is probably more realistic to assess patterns of different metabolites rather than single 827 
components. Moreover, due to the common basis of many transition period-related diseases, 828 
specific markers for individual diseases are improbable to emerge. In addition, comprehensive 829 
biological validation is needed before such measurements can indeed be considered as assessments 830 
of biomarkers for predictive and diagnostic purposes. However, the integration of several 831 
pathophysiological aspects e.g. lipolysis, ketogenesis and oxidative capacity in such patterns, by 832 
combining fatty acids, ketone bodies AND acylcarnitines, will likely yield more information than 833 
the classical measurement of NEFA and BHB. Moreover, the expansion of the dynamic range of 834 
detection of low-abundance proteins and metabolites is likely poised to pave the way for the 835 
detection of peripartum-specific biomarker patterns. Such (complex) biomarkers, will enable the 836 
identification of phenotypes less sensitive to metabolic stress and thus the development and 837 
implementation of strategies for early diagnosis, prognosis and prevention of transition-related 838 
diseases.  839 
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